Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single‐arm study-Reference-Cited by-同舟云学术

Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single‐arm study

Published:2020-06-29 Issue:5 Volume:25 Page:
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Hirata Yoshihiro¹²^ORCID,Yamada Atsuo¹,Niikura Ryota¹,Shichijo Satoki¹³^ORCID,Hayakawa Yoku¹,Koike Kazuhiko¹

Affiliation:

1. Department of Gastroenterology The University of Tokyo Tokyo Japan

2. Division of Advanced Genome Medicine The Institute of Medical Science The University of Tokyo Tokyo Japan

3. Department of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12719

Reference40 articles.

1. Helicobacter pyloriInfection and the Development of Gastric Cancer

2. Helicobacter pyloriInfection

3. Kyoto global consensus report onHelicobacter pylorigastritis

4. Changes in Seroepidemiological Pattern of Helicobacter Pylori and Hepatitis A Virus Over The Last 20 Years in Japan

5. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition;Kato M;Helicobacter,2019

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan;Journal of Clinical Medicine;2024-06-27

2. Refractoriness to anti‐Helicobacter pylori treatment attributed to phenotypic resistance patterns in patients with gastroduodenopathy in Guayaquil‐Ecuador;Helicobacter;2024-03

3. Vonoprazan a novel potassium competitive acid blocker; another leap forward;Gastroenterology Review;2024

4. Advances in the Study of Vonoprazan in the Treatment of Helicobacter pylori Infection;Advances in Clinical Medicine;2024

5. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection;World Journal of Gastroenterology;2023-05-28